Das Reizdarmsyndrom: kognitiv-behaviorale Faktoren und Interventionen

Aus psychiatrisch-psychosomatischer Perspektive kann das Reizdarmsyndrom als eine somatische Belastungsstörung mit Schwerpunkt der Symptomatik im gastrointestinalen Bereich begriffen werden. Dieser Beitrag gibt Einblick in aktuelles Wissen über psychologische Faktoren bei der Entstehung und Aufrechterhaltung der Symptomatik und leitet daraus Interventionsmöglichkeiten der kognitiven Verhaltenstherapie ab.

• Literatur

• 1 Layer P, Andresen V, Allescher H. et al. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Z Gastroenterol 2021; 59: 1323-1415
• 2 Oka P, Parr H, Barberio B. et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 908-917
• 3 Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000; 85: 317-332
• 4 Hauser G, Pletikosic S, Tkalcic M. Cognitive behavioral approach to understanding irritable bowel syndrome. World J Gastroenterol 2014; 20: 6744-6758
• 5 Dindo L, Lackner J. Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 2017; 15: 1500-1503
• 6 Windgassen S, Moss-Morris R, Chilcot J. et al. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. Br J Health Psychol 2017; 22: 701-736
• 7 Tanaka Y, Kanazawa M, Fukudo S. et al. Biopsychosocial Model of Irritable Bowel Syndrome. J Neurogastroenterol Motil 2011; 17: 131-139
• 8 David L, Stanculete MF, Bolba AR. et al. Coping Strategies and Irritable Bowel Syndrome: A Systematic Review. J Gastrointestin Liver Dis 2021; 30: 485-494
• 9 Keefer L, Ballou SK, Drossman DA. et al. A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction. Gastroenterol 2022; 162: 300-315
• 10 Porcelli P, De Carne M, Leandro G. Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome. Compr Psychiatry 2014; 55: 1647-1653
• 11 Henrich JF, Martin M. Altered attentional control linked to catastrophizing in patients with irritable bowel syndrome. Br J Health Psychol 2018; 23: 612-629
• 12 Aulenkamp J, Steinmüller K, Icenhour A. et al. From gut feeling to visceral pain: Effects of negative expectations in the context of the gut–brain axis. Schmerz 2022; 36: 182-188
• 13 Craske MG, Wolitzky-Taylor KB, Labus J. et al. A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther 2011; 49: 413-421
• 14 Labrenz F, Woud ML, Elsenbruch S. et al. The Good, the Bad, and the Ugly—Chances, Challenges, and Clinical Implications of Avoidance Research in Psychosomatic Medicine. Front Psychiatry 2022; 13
• 15 Labanski A, Langhorst J, Engler H. et al. Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: A transdisciplinary challenge. Psychoneuroendocrinol 2020; 111
• 16 Hetterich L, Stengel A. Psychotherapeutic Interventions in Irritable Bowel Syndrome. Front Psychiatry 2020; 11
• 17 Weibert E, Stengel A. The Role of Psychotherapy in the Treatment of Irritable Bowel Syndrome. Psychother Psychosom Med Psychol 2019; 69: 360-371
• 18 Windgassen S, Moss-Morris R, Goldsmith K. et al. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety. J Psychosom Res 2019; 118: 73-82
• 19 Gilliam WP, Schumann ME, Cunningham JL. et al. Pain catastrophizing as a treatment process variable in cognitive behavioural therapy for adults with chronic pain. Eur J Pain 2021; 25: 339-347
• 20 Ljótsson B, Hesser H, Andersson E. et al. Mechanisms of Change in an Exposure-Based Treatment for Irritable Bowel Syndrome. J Consult Clin Psychol 2013; 81: 1113-1126
• 21 Drossman DA, Ruddy J. Improving Patient-Provider Relationships to Improve Health Care. Clin Gastroenterol Hepatol 2020; 18: 1417-1426
• 22 Schmid J, Theysohn N, Gaß F. et al. Neural mechanisms mediating positive and negative treatment expectations in visceral pain: A functional magnetic resonance imaging study on placebo and nocebo effects in healthy volunteers. Pain 2013; 154: 2372-2380
• 23 Lu HC, Hsieh JC, Lu CL. et al. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: a 3T-fMRI study. Pain 2010; 148: 75-83
• 24 Bosman M, Elsenbruch S, Corsetti M. et al. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021; 6: 459-473
• 25 Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2015; 12: 472-485
• 26 Kaptchuk TJ, Kelley JM, Conboy LA. et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003
• 27 Lembo A, Kelley JM, Nee J. et al. Open-label placebo vs double-blind placebo for irritable bowel syndrome: A randomized clinical trial. Pain 2021; 162: 2428-2435
• 28 Nurko S, Saps M, Kossowsky J. et al. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial. JAMA Pediatr 2022; 176: 349-356
• 29 Elsenbruch S, Labrenz F. Nocebo Effects and Experimental Models in Visceral Pain. Int Rev Neurobiol 2018; 138: 285-306
• 30 Roderigo T, Benson S, Schöls M. et al. Effects of acute psychological stress on placebo and nocebo responses in a clinically relevant model of visceroception. Pain 2017; 158: 1489-1498